Adam Haque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adam Haque has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Ghosh
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK
2 shared publications - Stacie Hodge
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK
2 shared publications Angella Bryan
Division of Cardiovascular Sciences, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK; Department of Anaesthesia, Manchester University NHS Foundation Trust, Manchester, UK
1 shared publication- Angella Bryan
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK
1 shared publication - Basma Ellahi
University of Chester, Chester, UK
1 shared publication C. McCollum
1 shared publication
Latest Publications
- Open Access
Novel use of arm ergometry cardiopulmonary exercise testing for non-elective patients with chronic limb-threatening ischaemia: a feasibility trial
Objectives: To evaluate the feasibility, safety and acceptability of arm crank ergometry cardiopulmonary exercise testing (CPETarm) in patients with chronic limb threatening ischaemia (CLTI). Design: Prospective feasibility single-arm cohort study. Setting: A tertiary vascular surgery referral centre in Greater Manchester, UK. Participants: Adult inpatients admitted with CLTI and scheduled for non-elective vascular intervention. Interventions: Participants underwent bedside CPETarm using an incremental ramp protocol. Cardiopulmonary parameters measured included peak oxygen uptake, anaerobic threshold (AT), ventilatory equivalent for carbon dioxide at AT, peak work rate, oxygen pulse, maximum heart rate and respiratory exchange ratio. Primary and secondary outcome measures: Primary outcomes were feasibility domains including eligibility, recruitment, test completion, safety, practicality, implementation and patient acceptability. Secondary outcomes included the ability to obtain clinically relevant CPET variables for perioperative risk stratification. Results: 60 patients underwent CPETarm. 74% of CLTI inpatients met eligibility criteria and 71% of eligible patients consented to testing. CPETarm was completed to volitional exhaustion by 95% of participants, with anaerobic threshold identified in 68%. No major adverse events occurred during testing or within 24 hours post-test. 90% of CPETarm assessments were completed within 48 hours of the decision to proceed with intervention, without delaying surgery. The procedure was well tolerated and acceptable to patients. Conclusions: CPETarm is a feasible, safe and acceptable method for preoperative assessment in patients with CLTI who are unsuitable for conventional lower-limb CPET. Further research is required to establish modality-specific thresholds, evaluate prognostic value for postoperative outcomes and evaluate integration into perioperative care pathways. Trial registration number: NCT06404229 .
Open AccessNovel use of arm ergometry cardiopulmonary exercise testing for non-elective patients with chronic limb-threatening ischaemia: a feasibility trial
Objectives: To evaluate the feasibility, safety and acceptability of arm crank ergometry cardiopulmonary exercise testing (CPETarm) in patients with chronic limb threatening ischaemia (CLTI). Design: Prospective feasibility single-arm cohort study. Setting: A tertiary vascular surgery referral centre in Greater Manchester, UK. Participants: Adult inpatients admitted with CLTI and scheduled for non-elective vascular intervention. Interventions: Participants underwent bedside CPETarm using an incremental ramp protocol. Cardiopulmonary parameters measured included peak oxygen uptake, anaerobic threshold (AT), ventilatory equivalent for carbon dioxide at AT, peak work rate, oxygen pulse, maximum heart rate and respiratory exchange ratio. Primary and secondary outcome measures: Primary outcomes were feasibility domains including eligibility, recruitment, test completion, safety, practicality, implementation and patient acceptability. Secondary outcomes included the ability to obtain clinically relevant CPET variables for perioperative risk stratification. Results: 60 patients underwent CPETarm. 74% of CLTI inpatients met eligibility criteria and 71% of eligible patients consented to testing. CPETarm was completed to volitional exhaustion by 95% of participants, with anaerobic threshold identified in 68%. No major adverse events occurred during testing or within 24 hours post-test. 90% of CPETarm assessments were completed within 48 hours of the decision to proceed with intervention, without delaying surgery. The procedure was well tolerated and acceptable to patients. Conclusions: CPETarm is a feasible, safe and acceptable method for preoperative assessment in patients with CLTI who are unsuitable for conventional lower-limb CPET. Further research is required to establish modality-specific thresholds, evaluate prognostic value for postoperative outcomes and evaluate integration into perioperative care pathways. Trial registration number: NCT06404229 .
- Open Access
- 27 January 2026
- Published by BMJ in BMJ Innovations
- Vol. 12 (2) , 137-145
Respect Health: an innovative digital health home-based intervention for intermittent claudication
Introduction: Supervised exercise training is the first-line treatment for patients with peripheral arterial disease (PAD) presenting with intermittent claudication. However, provision, uptake and adherence to these programmes is notoriously poor in the National Health Service (NHS) in the UK. The ‘Respect Health PAD programme’ is a home-based digital innovation aimed to allow all patients with PAD access to National Institute of Health and Care Excellence (NICE)-compliant exercise services. We aim to describe the 1-year service evaluation from an ongoing pilot programme. Methods: A prospective observational service evaluation was conducted. Eligible patients were provided with specially engineered tablet computers preloaded with a 12-week, NICE-compliant exercise programme, smoking cessation course, patient education and motivational counselling via pre-recorded video. Simple home-based exercise equipment was also provided. Changes in initial (ICD) and absolute claudication distance (ACD) were measured on treadmill testing and quality of life using the Vascular Quality of Life Questionnaire-6 (VASCUQoL-6) tool. Data on accessibility, compliance and patient-reported outcomes were also investigated. Results: Between May 2022 and March 2024, 105 patients were enrolled, with a compliance rate of 77%. Mean (95% CI) increase in ICD (p<0.01) and ACD (p<0.01) were 219.6% (95% CI 111.9% to 327.3%) and 110.9% (95% CI 59.9% to 161.9%), respectively. Overall VASCUQOL-6 scores increased (p<0.01) from mean (95% CI) 11.3 (95% CI 10.6 to 12.0) to 15.1 (95% CI 14.0 to 16.2). 57% of current smokers reported this programme helped them stop smoking. Conclusions: This evaluation provides early evidence for a clinically promising and accessible method of delivering exercise therapy for patients with PAD. Its digital, home-based format offers potential for scalable, cost-effective implementation within the NHS.
- 27 January 2026
- Published by BMJ in BMJ Innovations
- Vol. 12 (2) , 137-145
Open AccessRespect Health: an innovative digital health home-based intervention for intermittent claudication
Introduction: Supervised exercise training is the first-line treatment for patients with peripheral arterial disease (PAD) presenting with intermittent claudication. However, provision, uptake and adherence to these programmes is notoriously poor in the National Health Service (NHS) in the UK. The ‘Respect Health PAD programme’ is a home-based digital innovation aimed to allow all patients with PAD access to National Institute of Health and Care Excellence (NICE)-compliant exercise services. We aim to describe the 1-year service evaluation from an ongoing pilot programme. Methods: A prospective observational service evaluation was conducted. Eligible patients were provided with specially engineered tablet computers preloaded with a 12-week, NICE-compliant exercise programme, smoking cessation course, patient education and motivational counselling via pre-recorded video. Simple home-based exercise equipment was also provided. Changes in initial (ICD) and absolute claudication distance (ACD) were measured on treadmill testing and quality of life using the Vascular Quality of Life Questionnaire-6 (VASCUQoL-6) tool. Data on accessibility, compliance and patient-reported outcomes were also investigated. Results: Between May 2022 and March 2024, 105 patients were enrolled, with a compliance rate of 77%. Mean (95% CI) increase in ICD (p<0.01) and ACD (p<0.01) were 219.6% (95% CI 111.9% to 327.3%) and 110.9% (95% CI 59.9% to 161.9%), respectively. Overall VASCUQOL-6 scores increased (p<0.01) from mean (95% CI) 11.3 (95% CI 10.6 to 12.0) to 15.1 (95% CI 14.0 to 16.2). 57% of current smokers reported this programme helped them stop smoking. Conclusions: This evaluation provides early evidence for a clinically promising and accessible method of delivering exercise therapy for patients with PAD. Its digital, home-based format offers potential for scalable, cost-effective implementation within the NHS.
- 1 November 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (2) , 337-338
Use of Cardiopulmonary Exercise Testing to Predict Outcomes for Female Patients Undergoing Abdominal Aortic Aneurysm Surgery
- 1 November 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (2) , 337-338
Use of Cardiopulmonary Exercise Testing to Predict Outcomes for Female Patients Undergoing Abdominal Aortic Aneurysm Surgery
- Open Access
- 4 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48271
Incidental Cardiovascular Abnormalities in the Abdominal Aortic Aneurysm (AAA) Surveillance Population During the AAA Get Fit Trial: A Case Series and Review of the Literature
Background The prevalence of cardiovascular disease and incidence of major adverse cardiovascular events (MACEs) is very high among the abdominal aortic aneurysm (AAA) surveillance population. Formal assessments of and interventions to reduce cardiovascular risk are not a routine part of the surveillance programme at present. However, its potential importance is highlighted by incidental findings during the AAA Get Fit Trial, a randomised controlled trial which included baseline cardiopulmonary exercise testing (CPET). We speculate that CPET can act as an opportunistic screening programme to identify cardiovascular disease in AAA surveillance patients. Methods The AAA Get Fit Trial was a prospective, randomised controlled trial at a tertiary vascular centre, Manchester University NHS Foundation Trust, conducted between November 2017 and August 2019. Patients underwent CPET at baseline, 8, 16, 24 and 36 weeks as well as clinical history and examination and blood tests. We report on incidental cardiovascular abnormalities diagnosed during the trial. Results Of the 59 participants in the trial, four (6.8%) were identified to have abnormal findings suggestive of unstable cardiovascular disease. On subsequent further investigation, two patients were diagnosed and treated for severe coronary artery disease after abnormal ECG findings were noted during CPET. One patient was diagnosed with unstable angina after obtaining a detailed history on baseline assessment which was treated medically before going on to have a successful elective AAA repair. Conclusions There is a high incidence of MACEs among this high-risk population both pre and perioperatively. Identifying and treating cardiovascular disease among the AAA surveillance population must be a focus of the future AAA screening programme.
- 4 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48271
Open AccessIncidental Cardiovascular Abnormalities in the Abdominal Aortic Aneurysm (AAA) Surveillance Population During the AAA Get Fit Trial: A Case Series and Review of the Literature
Background The prevalence of cardiovascular disease and incidence of major adverse cardiovascular events (MACEs) is very high among the abdominal aortic aneurysm (AAA) surveillance population. Formal assessments of and interventions to reduce cardiovascular risk are not a routine part of the surveillance programme at present. However, its potential importance is highlighted by incidental findings during the AAA Get Fit Trial, a randomised controlled trial which included baseline cardiopulmonary exercise testing (CPET). We speculate that CPET can act as an opportunistic screening programme to identify cardiovascular disease in AAA surveillance patients. Methods The AAA Get Fit Trial was a prospective, randomised controlled trial at a tertiary vascular centre, Manchester University NHS Foundation Trust, conducted between November 2017 and August 2019. Patients underwent CPET at baseline, 8, 16, 24 and 36 weeks as well as clinical history and examination and blood tests. We report on incidental cardiovascular abnormalities diagnosed during the trial. Results Of the 59 participants in the trial, four (6.8%) were identified to have abnormal findings suggestive of unstable cardiovascular disease. On subsequent further investigation, two patients were diagnosed and treated for severe coronary artery disease after abnormal ECG findings were noted during CPET. One patient was diagnosed with unstable angina after obtaining a detailed history on baseline assessment which was treated medically before going on to have a successful elective AAA repair. Conclusions There is a high incidence of MACEs among this high-risk population both pre and perioperatively. Identifying and treating cardiovascular disease among the AAA surveillance population must be a focus of the future AAA screening programme.
- 18 November 2022
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 76 (6) , 1755
The Abdominal Aortic Aneurysm Get Fit Trial: A Randomised Controlled Trial of Exercise to Improve Fitness in Patients with Abdominal Aortic Aneurysm
- 18 November 2022
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 76 (6) , 1755
The Abdominal Aortic Aneurysm Get Fit Trial: A Randomised Controlled Trial of Exercise to Improve Fitness in Patients with Abdominal Aortic Aneurysm
- Open Access
- 16 July 2022
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 64 (4) , 309-319
Editor's Choice – The Abdominal Aortic Aneurysm Get Fit Trial: A Randomised Controlled Trial of Exercise to Improve Fitness in Patients with Abdominal Aortic Aneurysm
- 16 July 2022
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 64 (4) , 309-319
Open AccessEditor's Choice – The Abdominal Aortic Aneurysm Get Fit Trial: A Randomised Controlled Trial of Exercise to Improve Fitness in Patients with Abdominal Aortic Aneurysm
- 1 April 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 81, 267-272
Early Results Using N-Terminal pro-B-Type Natriuretic Peptide (pro-BNP) as a Biomarker for the Efficacy of Secondary Extension Technique (SET) in Improving Myocardial Function in Dialysis Patients With High Flow Fistulas
- 1 April 2022
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 81, 267-272
Early Results Using N-Terminal pro-B-Type Natriuretic Peptide (pro-BNP) as a Biomarker for the Efficacy of Secondary Extension Technique (SET) in Improving Myocardial Function in Dialysis Patients With High Flow Fistulas
- 1 February 2022
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 104 (2) , 130-137
Few UK vascular centres offer a fully NICE-compliant supervised exercise programme: a national audit
Introduction: To determine the current (pre-COVID-19) provision of supervised exercise training (SET) for patients with peripheral arterial disease (PAD) in UK Vascular Centres. Methods: Hospital Trusts delivering vascular care to patients with PAD were identified from the National Vascular Registry and asked to complete an online questionnaire on their provisions for SET. If a centre offered SET, they were asked questions to determine whether the programme was compliant with NICE guidelines and the difficulties they faced delivering the service. If centres did not offer SET, they were asked what obstacles prevented them implement SET. Results: Of the 78 UK vascular centres, 59 (76%) responded and were included in the audit. Of these, 27 (46%) were able to offer SET but only 21 (36%) could offer it to all their patients with PAD. Only four (6.8%) offered SET that was fully compliant with current NICE guidelines. Reasons identified included insufficient funding, lack of resource and poor patient compliance. Conclusions: The benefits of SET are well established yet the availability of the service in the UK is poor. The reasons for this are readily identified but have not yet been overcome. Research on novel methods of delivering supervised exercise that mitigates existing barriers, such as home exercise with remote monitoring, should be prioritised to facilitate optimal management for our patients with PAD.
- 1 February 2022
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 104 (2) , 130-137
Few UK vascular centres offer a fully NICE-compliant supervised exercise programme: a national audit
Introduction: To determine the current (pre-COVID-19) provision of supervised exercise training (SET) for patients with peripheral arterial disease (PAD) in UK Vascular Centres. Methods: Hospital Trusts delivering vascular care to patients with PAD were identified from the National Vascular Registry and asked to complete an online questionnaire on their provisions for SET. If a centre offered SET, they were asked questions to determine whether the programme was compliant with NICE guidelines and the difficulties they faced delivering the service. If centres did not offer SET, they were asked what obstacles prevented them implement SET. Results: Of the 78 UK vascular centres, 59 (76%) responded and were included in the audit. Of these, 27 (46%) were able to offer SET but only 21 (36%) could offer it to all their patients with PAD. Only four (6.8%) offered SET that was fully compliant with current NICE guidelines. Reasons identified included insufficient funding, lack of resource and poor patient compliance. Conclusions: The benefits of SET are well established yet the availability of the service in the UK is poor. The reasons for this are readily identified but have not yet been overcome. Research on novel methods of delivering supervised exercise that mitigates existing barriers, such as home exercise with remote monitoring, should be prioritised to facilitate optimal management for our patients with PAD.